Phase I (PH I) Mad Refractory Solid Tumor Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00099606
Recruitment Status : Completed
First Posted : December 20, 2004
Last Update Posted : April 19, 2011
Information provided by:
Bristol-Myers Squibb